On February 20, 2026, the FDA issued warning letter #721455 to MEDVi, LLC
Glucose control The SURPASS studies enrolled populations that were similar in terms of baseline HbA1c levels, which ranged from 7.9 to 8.5% [2, 3, 59,60,61] and found a statistically significant reduction in HbA1c already at the 5 mg dose, demonstrating a greater efficacy of tirzepatide compared to placebo or active comparator [2, 3, 59,60,61]
GLP-1 therapies mark more than a scientific breakthrough, the officials wrote
More remarkably, 63 percent said that if their GLP-1 failed to help the condition it was initially prescribed to treat, they would either definitely or probably keep taking it for other benefits
A common pattern is this: softer carbs work better early, while denser, higher-fiber options are easier later in the day or once side effects ease
Note: Cooling duration is based on testing under ideal ambient conditions of 25C30C (77F86F)